References
1. Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI, Group IPTS. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 2009;124:1251-1258 e1223.
2. Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat Rev Dis Primers 2018;41.
3. Karimkhani C, Dellavalle RP, Coffeng LE, et al. Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013. JAMA Dermatol 2017;153:406-412.
4. Narla S, Silverberg JI. The Role of Environmental Exposures in Atopic Dermatitis. Curr Allergy Asthma Rep 2020;2074.
5. Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. The Lancet 2020;396:345-360.
6. Bookstaver PB, Bland CM, Griffin B, Stover KR, Eiland LS, McLaughlin M. A Review of Antibiotic Use in Pregnancy. Pharmacotherapy2015;35:1052-1062.
7. Pascal M, Perez-Gordo M, Caballero T, et al. Microbiome and Allergic Diseases. Front Immunol 2018;91584.
8. Tsakok T, McKeever TM, Yeo L, Flohr C. Does early life exposure to antibiotics increase the risk of eczema? A systematic review. Br J Dermatol 2013;169:983-991.
9. Huang FQ, Lu CY, Wu SP, Gong SZ, Zhao Y. Maternal exposure to antibiotics increases the risk of infant eczema before one year of life: a meta-analysis of observational studies. World J Pediatr2020;16:143-151.
10. Zhong Y, Zhang Y, Wang Y, Huang R. Maternal antibiotic exposure during pregnancy and the risk of allergic diseases in childhood: A meta-analysis. Pediatr Allergy Immunol 2021;32:445-456.
11. Cait A, Wedel A, Arntz JL, et al. Prenatal antibiotic exposure, asthma, and the atopic march: A systematic review and meta-analysis.Allergy 2022.
12. Lloyd-Lavery A, Solman L, Grindlay DJC, Rogers NK, Thomas KS, Harman KE. What’s new in atopic eczema? An analysis of systematic reviews published in 2016. Part 2: Epidemiology, aetiology and risk factors.Clin Exp Dermatol 2019;44:370-375.
13. Reynolds G, Vegh P, Fletcher J, et al. Developmental cell programs are co-opted in inflammatory skin disease. Science 2021;371.
14. Vangay P, Ward T, Gerber JS, Knights D. Antibiotics, pediatric dysbiosis, and disease. Cell Host Microbe 2015;17:553-564.
15. Tamburini S, Shen N, Wu HC, Clemente JC. The microbiome in early life: implications for health outcomes. Nat Med 2016;22:713-722.
16. Sanidad KZ, Zeng MY. Neonatal gut microbiome and immunity.Curr Opin Microbiol 2020;56:30-37.
17. Vuillermin PJ, Macia L, Nanan R, Tang ML, Collier F, Brix S. The maternal microbiome during pregnancy and allergic disease in the offspring. Semin Immunopathol 2017;39:669-675.
18. DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current Understanding of Dysbiosis in Disease in Human and Animal Models.Inflamm Bowel Dis 2016;22:1137-1150.
19. Kim J, Kim BE, Leung DYM. Pathophysiology of atopic dermatitis: Clinical implications. Allergy Asthma Proc 2019;40:84-92.
20. McKeever TM, Lewis SA, Smith C, Hubbard R. The importance of prenatal exposures on the development of allergic disease: a birth cohort study using the West Midlands General Practice Database. Am J Respir Crit Care Med 2002;166:827-832.
21. Dom S, Droste JH, Sariachvili MA, et al. Pre- and post-natal exposure to antibiotics and the development of eczema, recurrent wheezing and atopic sensitization in children up to the age of 4 years.Clin Exp Allergy 2010;40:1378-1387.
22. Stensballe LG, Simonsen J, Jensen SM, Bonnelykke K, Bisgaard H. Use of antibiotics during pregnancy increases the risk of asthma in early childhood. J Pediatr 2013;162:832-838 e833.
23. Sasaki M, Sakurai K, Shimojo N, Yamamoto M, Mori C, Japan Environment Children’s Study G. No association between prenatal antibiotic exposure and atopic dermatitis among Japanese infants.Pediatr Allergy Immunol 2020;31:218-221.
24. Mubanga M, Lundholm C, D’Onofrio BM, Stratmann M, Hedman A, Almqvist C. Association of Early Life Exposure to Antibiotics With Risk of Atopic Dermatitis in Sweden. JAMA Netw Open 2021;4e215245.
25. Earp E, Tsianou Z, Grindlay DJC, Rogers NK, Olabi B. What’s new in atopic eczema? An analysis of systematic reviews published in 2019. Part 1: Risk factors and prevention. Clin Exp Dermatol2021;46:1205-1210.
26. Hale G, Davies E, Grindlay DJC, Rogers NK, Harman KE. What’s new in atopic eczema? An analysis of systematic reviews published in 2017. Part 2: epidemiology, aetiology and risk factors. Clin Exp Dermatol2019;44:868-873.
27. Metzler S, Frei R, Schmausser-Hechfellner E, et al. Association between antibiotic treatment during pregnancy and infancy and the development of allergic diseases. Pediatr Allergy Immunol2019;30:423-433.
28. Wang JY, Liu LF, Chen CY, Huang YW, Hsiung CA, Tsai HJ. Acetaminophen and/or antibiotic use in early life and the development of childhood allergic diseases. Int J Epidemiol 2013;42:1087-1099.
29. Duong QA, Pittet LF, Curtis N, Zimmermann P. Antibiotic exposure and adverse long-term health outcomes in children: A systematic review and meta-analysis. J Infect 2022;85:213-300.
30. Stokholm J, Sevelsted A, Bønnelykke K, Bisgaard H. Maternal propensity for infections and risk of childhood asthma: a registry-based cohort study. The Lancet Respiratory Medicine 2014;2:631-637.
31. Loewen K, Monchka B, Mahmud SM, t Jong G, Azad MB. Prenatal antibiotic exposure and childhood asthma: a population-based study.Eur Respir J 2018;52.
32. Baiz N, Just J, Chastang J, et al. Maternal diet before and during pregnancy and risk of asthma and allergic rhinitis in children.Allergy Asthma Clin Immunol 2019;1540.
33. Timm S, Schlunssen V, Olsen J, Ramlau-Hansen CH. Prenatal antibiotics and atopic dermatitis among 18-month-old children in the Danish National Birth Cohort. Clin Exp Allergy 2017;47:929-936.